Market cap of $10M, with so much potential in the current health climate not only with Swine but as shown below.
Immunoxel has demonstrated that its superior normalizing and restorative action on the immune system can be used as a safe and effective means for prevention or treatment of multiple conditions including: influenza, acute respiratory diseases, hepatitis, tuberculosis, herpes, Candida, Chlamydia and other infectious and viral diseases.
Cholesterol Balance is recommended to assist the increase in ‘good’ cholesterol (HDL) and reduce ‘bad’ cholesterol (LDL) which in turn could also help to achieve normal blood pressure and lower the risk of heart attack. Cholesterol Balance has demonstrated a beneficial synergy when taken with a range of blood pressure medications as well as with cholesterol-reducing statin drugs. Clinical trials have shown that Cholesterol Balance can:
1) Activate absorption of deposited fat this can lead to excess body weight loss. 2)Normalize blood sugar levels in up to 40% of patients with diabetes 3) Positively affect immune responses 4) Improve liver function 5) Reduce vascular caused headaches, dizziness, buzzing in the ears, etc
Diabetic Balance is recommended for type 1 or 2 diabetes mellitus as well as for treatment of complications caused by diabetes. Light form diabetics may find Diabetic Balance sufficient as a main sugar normaliser and for advanced diabetics it may be possible to decrease use of synthetic hypoglycemic medications and thus lessen their side effects. The sugar normalizing effect of Diabetic Balance have been demonstrated in studies to reduce levels of cholesterol and lipoproteins in the blood, inhibit diabetic angiopathy and neuropathy, and markedly diminish appetite – which is also useful for diabetic weight control.
I have plenty - Its just unfortunate I paid more than the market currently values the stock. I am confident that this stock will fly in the coming months....
STI Price at posting:
1.6¢ Sentiment: None Disclosure: Held